Video content above is prompted by the following questions: How do treatment goals and outcome measures for bronchiectasis differ from those of COPD, particularly regarding FEV and exacerbation rates? In the absence of U.S.-based treatment guidelines, what resources do you use to make clinical decisions for bronchiectasis management?